Separation of plasma ‐derived exosomes into CD3(+) and CD3(‐) fractions allows for association of immune cell and tumor cell markers with disease activity in HNSCC patients

This article is protected by copyright. All rights reserved.

Source: Clinical and Experimental Immunology - February 12, 2018 Category: Allergy & Immunology Authors: Marie ‐Nicole Theodoraki, Thomas K. Hoffmann, Theresa L. Whiteside Tags: Original Article Source Type: research